T1	Participants 27 63	youth with autism spectrum disorders
T2	Participants 513 551	between the ages of 18-21 years of age
T3	Participants 805 845	24 (87.5 %) treatment group participants
T4	Participants 877 918	16 (6.25 %) of control group participants
